跳至主要内容
临床试验/CTRI/2025/07/090349
CTRI/2025/07/090349尚未招募2 期

EVALUATING THE THERAPEUTIC EFFECTS OF KOTHANDA ADANGAL (VARMA THERAPY) IN MANAGEMENT OF STRESS – AN OPEN CLINICAL TRIAL

Mangaleshwari1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年7月19日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

This study evaluates the efficacy of Kothanda Adangal (Varma Therapy) in reducing stress levels and improving sleep quality in patients with chronic stress. The primary objective is to assess the effectiveness of Kothanda Adangal in reducing stress levels, as measured by the Perceived Stress Scale (PSS), while the secondary objective is to evaluate its impact on sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI). The study involves 40 patients with chronic stress who will undergo Kothanda Adangal therapy, preceded by purgation with Agasthiyar Kuzhambu. Patients will be assessed at baseline, post-treatment (7 weeks), and follow-up (2 months). The study aims to provide insights into the effectiveness of Kothanda Adangal in managing chronic stress and improving sleep quality.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients who are having the symptoms of Headaches,Tense muscles, sore neck and back,Fatigue, Anxiety, worry, phobias, Insomnia, Irritability, Bouts of anger, Boredom, Depression , Binge eating, Constipation and Restlessness.

排除标准

  • patient who will meet any of the following criteria will be excluded from participation in this study: Severe mental health conditions: Patients with severe mental health conditions, such as psychosis, bipolar disorder, or suicidal ideation Chronic medical conditions: Patients with chronic medical conditions, such as diabetes, hypertension, or cardiovascular disease, that may interfere with the study Pregnancy or breastfeeding Current therapy: Patients who are currently receiving therapy or treatment for stress or anxiety Substance abuse: Patients with a history of substance abuse or addiction Contraindications to Kothanda Adangal: Patients with contraindications to Kothanda Adangal, such as bleeding disorders or pacemakers Inability to provide informed consent Coronary artery disease Tuberculosis Any other serious illness.

结局指标

主要结局

未指定

次要结局

  • Pittsburgh Sleep Quality Index (PSQI): The PSQI is a 19-item self-report questionnaire that assesses sleep quality & disturbances over a 1-month time interval.

研究者

发起方
Mangaleshwari
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Mangaleshwari

National Institute of Siddha

研究点 (1)

Loading locations...

相似试验